Logan Capital Management’s Eli Lilly LLY Stock Holding History

Logan Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-27,808	Closed	-$28.2M	–	412
2025 Q4	$29.9M	Sell	27,808 -441	-2%	-$422K	1.26%	14
2025 Q3	$21.6M	Sell	28,249 -1,577	-5%	-$1.17M	0.91%	24
2025 Q2	$23.2M	Sell	29,826 -3,086	-9%	-$2.4M	1.08%	18
2025 Q1	$27.2M	Buy	32,912 +718	+2%	+$597K	1.24%	14
2024 Q4	$24.9M	Sell	32,194 -125	-0.4%	-$104K	1.04%	21
2024 Q3	$28.6M	Sell	32,319 -128	-0.4%	-$115K	1.18%	16
2024 Q2	$29.4M	Sell	32,447 -62	-0.2%	-$49.6K	1.27%	13
2024 Q1	$25.3M	Sell	32,509 -90	-0.3%	-$64K	1.08%	19
2023 Q4	$19M	Sell	32,599 -2,691	-8%	-$1.57M	0.89%	29
2023 Q3	$19M	Buy	35,290 +302	+0.9%	+$156K	0.96%	24
2023 Q2	$16.4M	Buy	34,988 +194	+0.6%	+$81.4K	0.79%	33
2023 Q1	$11.9M	Buy	34,794 +337	+1%	+$114K	0.58%	54
2022 Q4	$12.6M	Buy	34,457 +4,221	+14%	+$1.5M	0.65%	50
2022 Q3	$9.78M	Buy	30,236 +4,454	+17%	+$1.41M	0.59%	55
2022 Q2	$8.36M	Hold	25,782	–	–	0.48%	68
2022 Q1	$7.38M	Hold	25,782	–	–	0.36%	87
2021 Q4	$7.12M	Buy	25,782 +200	+0.8%	+$50.7K	0.31%	94
2021 Q3	$5.91M	Hold	25,582	–	–	0.28%	101
2021 Q2	$5.87M	Hold	25,582	–	–	0.27%	99
2021 Q1	$4.78M	Buy	25,582 +419	+2%	+$82K	0.24%	107
2020 Q4	$4.25M	Sell	25,163 -122	-0.5%	-$18.2K	0.21%	111
2020 Q3	$3.74M	Hold	25,285	–	–	0.2%	122
2020 Q2	$4.15M	Sell	25,285 -279	-1%	-$42.8K	0.24%	101
2020 Q1	$3.55M	Sell	25,564 -2,030	-7%	-$279K	0.25%	102
2019 Q4	$3.63M	Buy	27,594 +30	+0.1%	+$3.48K	0.2%	118
2019 Q3	$3.08M	Hold	27,564	–	–	0.18%	125
2019 Q2	$3.05M	Hold	27,564	–	–	0.18%	124
2019 Q1	$3.58M	Sell	27,564 -187	-0.7%	-$22.7K	0.22%	110
2018 Q4	$3.21M	Hold	27,751	–	–	0.25%	103
2018 Q3	$2.98M	Buy	27,751 +187	+0.7%	+$18.7K	0.2%	108
2018 Q2	$2.35M	Sell	27,564 -59	-0.2%	-$4.85K	0.16%	113
2018 Q1	$2.14M	Sell	27,623 -656	-2%	-$52.8K	0.15%	110
2017 Q4	$2.39M	Hold	28,279	–	–	0.17%	108
2017 Q3	$2.42M	Hold	28,279	–	–	0.17%	100
2017 Q2	$2.33M	Buy	28,279 +229	+0.8%	+$18.7K	0.17%	99
2017 Q1	$2.36M	Buy	28,050 +715	+3%	+$57.3K	0.18%	100
2016 Q4	$2.01M	Hold	27,335	–	–	0.16%	107
2016 Q3	$2.19M	Hold	27,335	–	–	0.18%	103
2016 Q2	$2.15M	Sell	27,335 -5,500	-17%	-$414K	0.18%	95
2016 Q1	$2.36M	Buy	32,835 +335	+1%	+$25.3K	0.19%	100
2015 Q4	$2.74M	Hold	32,500	–	–	0.22%	95
2015 Q3	$2.72M	Sell	32,500 -1,000	-3%	-$84.4K	0.23%	93
2015 Q2	$2.8M	Hold	33,500	–	–	0.21%	101
2015 Q1	$2.43M	Sell	33,500 -170	-0.5%	-$12.1K	0.17%	104
2014 Q4	$2.32M	Sell	33,670 -1,500	-4%	-$101K	0.17%	109
2014 Q3	$2.28M	Hold	35,170	–	–	0.16%	103
2014 Q2	$2.19M	Buy	35,170 +170	+0.5%	+$10.1K	0.15%	103
2014 Q1	$2.06M	Hold	35,000	–	–	0.15%	104
2013 Q4	$1.78M	Hold	35,000	–	–	0.13%	111
2013 Q3	$1.76M	Sell	35,000 -8,000	-19%	-$419K	0.13%	109
2013 Q2	$1.85M	Buy	+43,000	New	+$2.34M	0.15%	106

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Logan Capital Management's LLY Position: Q1 2026 in Review

Logan Capital Management sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 27,808 shares — an estimated $28.2M sold.

Logan Capital Management first reported a position in LLY in Q2 2013 and held it in 51 quarters. The position peaked at $29.9M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Logan Capital Management reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
Logan Capital Management sold 27,808 Eli Lilly shares in Q1 2026, an estimated $28.2M.
Logan Capital Management first reported a position in Eli Lilly in Q2 2013 and held it in 51 quarters.
Logan Capital Management's Eli Lilly position peaked at $29.9M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Logan Capital Management's 13F filing for Q1 2026, filed 8 May 2026.